Typhoid Fever
文献摘要
Typhoid fever and paratyphoid fever are clinically indistinguishable febrile multisystemic illnesses caused by Salmonella enterica serotypes Typhi (S Typhi) and Paratyphi (S Paratyphi) A, B, and C. Collectively known as enteric fever, these diseases sicken more than 9 million people and kill 110,000 every year worldwide.[WHO. Typhoid Fact Sheet] Enteric fever is the leading cause of community-acquired bloodstream infections in South and Southeast Asia. A reportable disease in the United States (US) and many other resource-rich countries, enteric fever is second only to malaria as a cause of severe and sometimes life-threatening infection in travelers.[2] Following an incubation period of 6 to 30 days, enteric fever presents insidiously with the gradual onset of fever, fatigue, anorexia, headache, malaise, and abdominal symptoms. Delayed or inadequate treatment can lead to meningitis, sepsis, or intestinal perforation. Widespread use of successive antibiotics has contributed to a rather rapid increase in antimicrobial resistance among S Typhi and S Paratyphi strains. With the widespread use of successive antibiotics, the recent emergence of extensively drug-resistant (XDR) strains has greatly complicated treatment and raised alarms. S Typhi and S Paratyphi are said to spread by the 4 Fs: flies, fingers, feces, and fomites. Enteric fever primarily affects people who live in or travel to resource-limited countries that lack clean water, adequate sanitation, and hygiene, collectively known as water, sanitation, and hygiene (WASH). Improved WASH infrastructure is the foundation for decreasing the incidence of enteric fever and other diseases spread via the fecal-oral route. Historically, enteric fever has received less investment and attention than the 3 major infectious diseases: HIV/AIDS, tuberculosis, and malaria. However, concern about the emergence of potentially untreatable strains has renewed enteric fever control efforts. Recently developed typhoid conjugate vaccines, improved surveillance and characterization of antimicrobial resistance patterns, and WASH initiatives have decreased the disease burden. This activity covers the epidemiology, pathophysiology, treatment, complications, patient education, prevention, and role of the interprofessional team in improving patient care and reducing the burden of enteric fever. Despite persistent barriers to disease control, recent advances support continued efforts to reduce or potentially eliminate the future impact of enteric fever.